Cargando…

Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients

The goal of this study was to evaluate the relationship between early change in psychosocial function independent of depression severity and longer-term symptomatic remission. Participants of Combining Medications to Enhance Depression Outcomes trial were randomly selected for model selection (n = 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jha, Manish K., Minhajuddin, Abu, Greer, Tracy L., Carmody, Thomas, Rush, Augustus John, Trivedi, Madhukar H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193346/ https://www.ncbi.nlm.nih.gov/pubmed/28030546 http://dx.doi.org/10.1371/journal.pone.0167901

Ejemplares similares

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
por: Jha, Manish K, et al.
Publicado: (2017)

Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale
por: Jha, Manish K, et al.
Publicado: (2017)

Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials
por: Jha, Manish K, et al.
Publicado: (2019)

Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination
por: Jha, Manish K, et al.
Publicado: (2017)

Psychometric Properties of the Concise Associated Symptom Tracking Scale and Validation of Clinical Utility in the EMBARC Study
por: Minhajuddin, Abu, et al.
Publicado: (2020)

Higher S100B Levels Predict Persistently Elevated Anhedonia with Escitalopram Monotherapy Versus Antidepressant Combinations: Findings from CO-MED Trial
por: Jha, Manish K., et al.
Publicado: (2019)

Accurately identifying patients who are excellent candidates or unsuitable for a medication: a novel approach
por: South, Charles, et al.
Publicado: (2017)

Fibroblast growth factor 21 (FGF21) is increased in MDD and interacts with body mass index (BMI) to affect depression trajectory
por: Mason, Brittany L., et al.
Publicado: (2022)

Psychometric and Clinical Evaluation of the Clinician (VQIDS-C(5)) and Self-Report (VQIDS-SR(5)) Versions of the Very Quick Inventory of Depressive Symptoms
por: Rush, A John, et al.
Publicado: (2022)

Item response analysis of the inventory of depressive symptomatology
por: Bernstein, Ira H, et al.
Publicado: (2006)

Leveraging the microbiome to understand clinical heterogeneity in depression: findings from the T-RAD study
por: Chin Fatt, Cherise R., et al.
Publicado: (2023)

Treatment strategies to improve and sustain remission in major depressive disorder
por: Madhukar H., Trivedi, et al.
Publicado: (2008)

A complier average causal effect analysis of the Stimulant Reduction Intervention using dosed exercise study
por: Carmody, Thomas, et al.
Publicado: (2018)

Immune characterization of suicidal behavior in female adolescents
por: Chin Fatt, Cherise R., et al.
Publicado: (2022)

VitalSign(6): A Primary Care First (PCP-First) Model for Universal Screening and Measurement-Based Care for Depression
por: Trivedi, Madhukar H., et al.
Publicado: (2019)

Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome
por: Valencia, Marcelo, et al.
Publicado: (2015)

Impact of the COVID-19 pandemic on adults with current and prior depression: initial findings from the longitudinal Texas RAD study
por: Czysz, Andrew H., et al.
Publicado: (2021)

Pro-Inflammatory Cytokines as Predictors of Antidepressant Effects of Exercise in Major Depressive Disorder
por: Rethorst, Chad D., et al.
Publicado: (2012)

Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression
por: Kumar, Arun, et al.
Publicado: (2019)

Clinically Significant Changes in the 17- and 6-Item Hamilton Rating Scales for Depression: A STAR*D Report
por: Rush, Augustus John, et al.
Publicado: (2021)

The 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR(9)) measure of suicidal risk: Performance in adult primary care patients
por: Nandy, Karabi, et al.
Publicado: (2023)

The Longer-Term Psychosocial Development of Adolescents: Child Development Accounts and the Role of Mentoring
por: Chan, Ko Ling, et al.
Publicado: (2018)

Does Duloxetine Improve Cognitive Function Independently of Its Antidepressant Effect in Patients with Major Depressive Disorder and Subjective Reports of Cognitive Dysfunction?
por: Greer, Tracy L., et al.
Publicado: (2014)

Broader conceptualization of remission assessed by the remission from depression questionnaire and its association with symptomatic remission: a prospective, multicenter, observational study
por: Montoya, Alonso, et al.
Publicado: (2016)

A Systematic Review and Meta-Analysis of Depression and Protein–Energy Wasting in Kidney Disease
por: Gregg, L. Parker, et al.
Publicado: (2019)

Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation
por: Jha, Manish K., et al.
Publicado: (2018)

Remission of symptoms is not equal to functional recovery: Psychosocial functioning impairment in major depression
por: Yang, Hao, et al.
Publicado: (2022)

Symptomatic Remission and Counterfactual Reasoning in Schizophrenia
por: Albacete, Auria, et al.
Publicado: (2017)

The Concise Health Risk Tracking ‐ Self‐Report (CHRT‐SR)—A measure of suicidal risk: Performance in adolescent outpatients
por: Nandy, Karabi, et al.
Publicado: (2022)

Adaption of tele-behavioral activation to increase physical activity in depression: Protocol for iterative development and evaluation
por: Rethorst, Chad D., et al.
Publicado: (2023)

Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of life
por: Sackeim, Harold A., et al.
Publicado: (2023)

What moderator characteristics are associated with better prognosis for depression?
por: Trivedi, Madhukar H, et al.
Publicado: (2005)

IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder
por: Rethorst, C D, et al.
Publicado: (2015)

Dextrose Prolotherapy for Symptomatic Grade IV Knee Osteoarthritis: A Pilot Study of Early and Longer-Term Analgesia and Pain-Specific Cytokine Concentrations
por: Topol, Gastón Andrés, et al.
Publicado: (2022)

Spontaneous remission of fully symptomatic visceral leishmaniasis
por: Mouri, Oussama, et al.
Publicado: (2015)

Toward an online cognitive and emotional battery to predict treatment remission in depression
por: Gordon, Evian, et al.
Publicado: (2015)

Bipolar disorder correlated to shorter remission latency and borderline personality disorder symptom severity to longer in depression – a prospective cohort study of major depressive patients
por: Söderholm, J., et al.
Publicado: (2022)

Multi-Omics Characterization of Early- and Adult-Onset Major Depressive Disorder
por: Grant, Caroline W., et al.
Publicado: (2022)

Symptomatic remission affects employment outcomes in schizophrenia patients
por: Wang, San-Ping, et al.
Publicado: (2020)

Clinical and psychosocial remission in schizophrenia: correlations with antipsychotic treatment
por: Barak, Yoram, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0ljjrlo095cmba2kv5dktmg68k